| |
| |
|
| Insider
Information: |
Tierney David S |
| Relationship: |
CEO, Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
8,284,057 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,234,546 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,284,057 |
|
|
| Total
Value |
$8,234,546 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
5
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.5
|
| Percentage
Gain/Loss : |
 12.5%
|
80.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Catalyst Pharmaceutical Partners... |
CPRX |
Director |
2024-08-21 |
348,874 |
|
0 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Director |
2009-10-06 |
267,948 |
2007-02-01 |
0 |
Premium* |
|
|
Bioject Medical Technologies Inc |
BJCT |
Director |
2014-04-30 |
156,400 |
2007-12-14 |
0 |
Premium* |
|
|
Kempharm, Inc |
KMPH |
Director |
2023-03-09 |
10,835 |
2015-04-21 |
0 |
Premium* |
|
|
Timber Pharmaceuticals Inc |
TMBR |
CEO, Director |
2018-09-19 |
7,500,000 |
2018-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
48,200 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
58,427 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-06-28 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
68,654 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-09-12 |
4 |
A |
$1.60 |
$32,000 |
D/D |
20,000 |
98,654 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-09-28 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
108,881 |
0 |
- |
|
| BJCT |
Bioject Medical Technolog... |
Director |
– • – |
2007-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2007-12-31 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
143,432 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2008-01-09 |
4 |
A |
$1.48 |
$36,000 |
D/D |
24,324 |
133,205 |
0 |
- |
|
| BJCT |
Bioject Medical Technolog... |
Director |
– • – |
2008-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
6,000 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2008-08-12 |
4 |
A |
$1.47 |
$103,370 |
D/D |
70,320 |
213,752 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2008-09-15 |
4 |
A |
$0.13 |
$1,477 |
D/D |
11,364 |
225,116 |
0 |
- |
|
| BJCT |
Bioject Medical Technolog... |
Director |
– • – |
2008-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
42,000 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
246,532 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2009-03-06 |
4 |
B |
$1.55 |
$4,650 |
D/D |
3,000 |
185,402 |
2.31 |
- |
|
| BJCT |
Bioject Medical Technolog... |
Director |
– • – |
2009-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
78,000 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2009-06-09 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
257,240 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2009-10-06 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
267,948 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2012-05-29 |
4 |
B |
$0.58 |
$11,696 |
D/D |
20,000 |
205,401 |
2.39 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2013-10-23 |
4 |
B |
$2.03 |
$16,240 |
D/D |
8,000 |
213,401 |
2.39 |
- |
|
| BJCT |
Bioject Medical Technolog... |
Director |
– • – |
2014-04-30 |
4 |
OE |
$0.75 |
$58,800 |
D/D |
78,400 |
156,400 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2014-10-16 |
4 |
OE |
$0.90 |
$27,000 |
D/D |
30,000 |
243,401 |
0 |
- |
|
| KMPH |
Kempharm, Inc |
Director |
– • – |
2015-04-21 |
4 |
B |
$11.00 |
$55,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2015-10-27 |
4 |
OE |
$1.09 |
$32,700 |
D/D |
30,000 |
273,401 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Director |
– • – |
2015-10-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
263,401 |
0 |
- |
|
| KMPH |
Kempharm, Inc |
Director |
• • – |
2017-03-20 |
4 |
B |
$4.20 |
$4,200 |
D/D |
1,000 |
6,000 |
2.31 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
